{"certainAgreement":{"otherDetails":"Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor's review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor's designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"pointOfContact":{"email":"ustevatrials@tevapharm.com","organization":"Teva Branded Pharmaceutical Products, R&D Inc.","phone":"215-591-3000","title":"Director, Clinical Research"}}